Besides, one phase II clinical trial reported that a CCA patient who participated in the adoptive cell therapy experiment and transfused mutation-specific CD4+ T cells after chemotherapy failure, and the tumor achieved partial remission 7 months later (78). Here, CD4 is linked to cholangiocarcinoma.